Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-β 1-40 peptide in mice

Neuropeptides

Volumn 44, Issue 2, 2010, Pages 93-97

  Amaral, Fabio Agostini ^a   Lemos, Mayra Tolentino Resk ^a   Dong, Karis Ester ^a   Bittencourt, Maria Fernanda Queiroz Prado ^a   Caetano, Ariadiny Lima ^a   Pesquero, João Bosco ^c   Viel, Tania Araujo ^b   Buck, Hudson Sousa ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer; B1 receptor; B2 receptor; Bradykinin; Neurodegeneration; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; GENE DELETION; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMIDITY; LATERAL BRAIN VENTRICLE; LEARNING; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STRAIN DIFFERENCE; TEMPERATURE;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BRAIN; MALE; MEMORY; MEMORY DISORDERS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; PEPTIDE FRAGMENTS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2;

MUS; RATTUS;

EID: 77049092287     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.10.006     Document Type: Article

References (26)

1. Duka I., Kintsurashvili E., Gavras I., Johns C., Bresnahan M., and Gavras H. Vasoactive potential of the B1 bradykinin receptor in normotension and hypertension. Circ. Res. 88 (2001) 275-281
2. Duka I., Duka A., Kintsurashvili E., Johns C., Gavras I., and Gavras H. Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin. Hypertension 42 (2003) 1021-1025
3. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates. third ed. (2007), Academic Press, San Diego
4. Frautschy S.A., Horn D.L., Sigel J.J., Harris-White M.E., Mendoza J.J., Yang F., Saido T.C., and Cole G.M. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 18 20 (1998) 8311-8321
5. Huang H.M., Lin T.A., Sun G.Y., and Gibson G.E. Increased inositol 1,4,5-trisphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 64 2 (1995) 761-766
6. Iores-Marçal L.M., Viel T.A., Buck H.S., Nunes V.A., Gozzo A.J., Cruz-Silva I., Miranda A., Shimamoto K., Ura N., and Araujo M.S. Brain prolyl oligopeptidase inactivates bradykinin in a model of Alzheimer's disease. Peptides 27 12 (2006) 3363-3369
7. Jong Y.J., Dalemar L.R., Seehra K., and Baenziger N.L. Bradykinin receptor modulation in cellular models of aging and Alzheimer's disease. Int. Immunopharmacol. 2 13-14 (2002) 1833-1840
8. Jong Y.J., Ford S.R., Seehra K., Malave V.B., and Baenziger N.L. Alzheimer's disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation. FASEB J. 17 15 (2003) 2319-2321
9. Joseph K., Shibayama Y., Nakazawa Y., Peerschke E.I., Ghebrehiwet B., and Kaplan A.P. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology 43 (1999) 203-210
10. Leeb-Lundberg L.M.F., Marceau F., Ller-Esterl W.M., Pettibone D.J., and Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57 (2005) 27-77
11. Lemos, M.T.R., Dong, K.E., Amaral, F.A., Bittencourt, M.F.Q.P., Caetano, A.L., Pesquero, J.B., Viel, T.A., Buck, H.S., Role of kinin B1 and B2 receptors on memory consolidation during aging process of mice. Neuropeptides, submitted for publication.
12. Maestri R., Milia A.F., Salis M.B., Graiani G., Lagrasta C., Monica M., Corradi D., Emanueli C., and Madeddu P. Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 41 (2003) 1151-1155
13. Marceau F., Hess J.F., and Bachvarov D.R. The B1 receptors for kinins. Pharmacol. Rev. 50 (1998) 357-386
14. McEachern A.E., Shelton E.R., Bhakta S., Obernolte R., Bach C., Zuppan P., Fujisaki J., Aldrich R.W., and Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc. Natl. Acad. Sci. USA 88 17 (1991) 7724-7728
15. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
16. Menke J.G., Borkowski J.A., Bierilo K.K., MacNeil T., Derrick A.W., Schneck K.A., Ransom R.W., Strader C.D., Linemeyer D.L., and Hess J.F. Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 269 34 (1994) 21583-21586
17. Nitsch R.M., Kim C., and Growdon J.H. Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochem. Res. 23 5 (1998) 807-814
18. Prat A., Weinrib L., Becher B., Poirier J., Duquette P., Couture R., and Antel J.P. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology 53 (1999) 2087-2092
19. Prat A., Biernacki K., Pouly S., Nalbantoglu J., Couture R., and Antel J.P. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropat. Exp. Neurol. 59 (2000) 896-906
20. Prediger R.D., Medeiros R., Pandolfo P., Duarte F.S., Passos G.F., Pesquero J.B., Campos M.M., Calixto J.B., and Takahashi R.N. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience 151 3 (2008) 631-643
21. Racchi M., Ianna P., Binetti G., Trabucchi M., and Govoni S. Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease. Biochem. J. 330 Pt 3 (1998) 1271-1275
22. Regoli D., and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32 (1980) 1-46
23. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., and Suuronen T. Inflammation in Alzheimer's disease: amyloid-b oligomers trigger innate immunity defence via pattern recognition receptors. Prog. Neurobiol. 87 (2009) 181-194
24. Vanzeler M.L., Felicio L.F., and Nasello A.G. Effects of chronic domperidone treatment on rat conditioned avoidance behavior. Braz. J. Med. Biol. Res. 23 9 (1990) 865-868
25. Viel T.A., Lima Caetano A., Nasello A.G., Lancelotti C.L., Nunes V.A., Araujo M.S., and Buck H.S. Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats. Neurobiol. Aging 29 12 (2008) 1805-1814
26. Zhao W.Q., Ravindranath L., Mohamed A.S., Zohar O., Chen G.H., Lyketsos C.G., Etcheberrigaray R., and Alkon D.L. MAPkinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblast. Neurobiol. Dis. 11 1 (2002) 166-183